Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.11 USD | -1.09% | -2.06% | -18.01% |
04-22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
03-28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.01% | 3.14B | |
+18.46% | 7.66B | |
+22.71% | 3.85B | |
-19.65% | 1.35B | |
-30.65% | 1.18B | |
+5.26% | 934M | |
-34.81% | 911M | |
-25.17% | 840M | |
-15.56% | 726M | |
-12.45% | 597M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Evolent Health, Inc. Revises Earnings Guidance for the Full Year of 2021